Top Markets
#1 Useless Coin Useless Coin +39.98%
#2 StonkBroker StonkBroker +38.07%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.69%
#4 0G 0G +34.77%
#5 SAFEcoin SAFEcoin +30.08%
#6 Dogs Dogs +19.32%
#7 Arbitrum Arbitrum +18.58%
#8 Full Moon Full Moon +17.84%
#9 Zora Zora +17.77%
#10 Notcoin Notcoin +17.21%
Coin of the day
Useless Coin Useless Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Classifica tra le azioni #13823
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Prezzo delle azioni
$4.36
Capitalizzazione di mercato
$457.32M
Variazione (1 giorno)
0.69%
Variazione (1 anno)
289.29%
Paese
US
Scambia Relmada Therapeutics, Inc. (RLMD)

Categoria

Healthcare
Il prezzo RLMD con la capitalizzazione del mercato della B
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
RLMD
$4.36
Capitalizzazione di mercato di Relmada Therapeutics, Inc.(RLMD)
Capitalizzazione di mercato: $457.32M
A partire dal August 2026, Relmada Therapeutics, Inc. ha una capitalizzazione di mercato pari a $457.32M. Questo rende Relmada Therapeutics, Inc. la 13823rd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Relmada Therapeutics, Inc. dal 2014 al 2026
RLMD in paragone con la classifica dei più popolari stocks
Il prezzo per RLMD Attivo B Capitalizzazione del mercato a B Risultati
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$50,784.67 $457.32M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.327T +1,164,685.90%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$44,283.31 $457.32M
Apple Inc. Apple Inc.
AAPL
$4.645T +1,015,572.25%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$38,805.04 $457.32M
Alphabet Inc. Alphabet Inc.
GOOG
$4.070T +889,923.79%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$36,081.42 $457.32M
Microsoft Corporation Microsoft Corporation
MSFT
$3.785T +827,455.52%
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.
$26,600.47 $457.32M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.790T +610,002.42%